Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | TACR1 | P25103 | 2/20 | 0.52 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.52 |
| ▸ | CMA1 | P23946 | 3/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | CTSG | P08311 | 1/20 | 0.50 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2517659 | 0.95 | SLC6A2 (0.53) | SLC6A2TACR1PSMB9OPRM1OPRD1 | |
| SCHEMBL2517666 | 0.95 | SLC6A2 (0.53) | SLC6A2TACR1PSMB9OPRM1OPRD1 | |
| SCHEMBL1940130 | 0.92 | SLC6A2 (0.51) | SLC6A2PSMB9OPRM1OPRD1OPRK1 | |
| SCHEMBL29391626 | 0.92 | CALCRL (0.53) | SLC6A2TACR1PSMB9CMA1OPRM1 | |
| SCHEMBL30633420 | 0.90 | SLC6A2 (0.62) | SLC6A2PSMB9CMA1OPRM1OPRD1 | |
| SCHEMBL28522301 | 0.88 | LNPEP (0.53) | SLC6A2ELANECTSG | |
| SCHEMBL28522299 | 0.88 | LNPEP (0.53) | SLC6A2ELANECTSG | |
| SCHEMBL30050973 | 0.87 | ITGB1 (0.57) | SLC6A2TACR1ACE | |
| SCHEMBL15270934 | 0.86 | LNPEP (0.52) | SLC6A2CMA1ELANECTSG | |
| SCHEMBL15270931 | 0.86 | LNPEP (0.52) | SLC6A2CMA1ELANECTSG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024211447-A1 | TP508 MRNAS | CHRYSALIS BIOTHERAPEUTICS (US) | 2024-10-10 | — | — | WO | disclosed |